Trials / Completed
CompletedNCT03072641
Using Probiotics to Reactivate Tumor Suppressor Genes in Colon Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Vastra Gotaland Region · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine if probiotic bacteria have a beneficial effect on the colon cancer-associated microbiota and epigenetic alterations in colon cancer. Dietary supplementation consists of two ProBion Clinica tablets, yielding a daily dose of 1.4 x 10 ˄ 10 Bifidobacterium lactis Bl-04 (ATCC SD5219), 7x10 ˄ 9 Lactobacillus acidophilus NCFM (ATCC 700396), and 0.63 g inulin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | ProBion Clinica |
Timeline
- Start date
- 2010-06-03
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2017-03-07
- Last updated
- 2017-03-07
Source: ClinicalTrials.gov record NCT03072641. Inclusion in this directory is not an endorsement.